Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. | 767,830 | reported | 03 Feb 2026 | tx 26+5,023,985−1,980,496 |
| IDENIX PHARMACEUTICALS INC | 400,000 | reported | 10 Feb 2010 | tx 10+1,710,000−269,345 |
| Kezar Life Sciences, Inc. | 26,000 | reported | 28 Jun 2021 | tx 7+131,631−87,839 |
| ABG Acquisition Corp. I | 0 | reported | 01 Mar 2023 | tx 1−32,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 300,000 | 1.24 USD | |
| 31 Jan 2026 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 106,093 | 4.24 USD | |
| 31 Jan 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 272,983 | — | |
| 03 Feb 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 300,000 | 0.00 USD | deriv |
| 31 Jan 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 173,466 | 0.00 USD | deriv |
| 31 Jan 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 99,517 | 0.00 USD | deriv |
| 31 Jan 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 99,517 | — | |
| 31 Jan 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 173,467 | — | |
| 31 Jan 2025 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 88,601 | 3.06 USD | |
| 31 Jan 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 440,000 | 0.00 USD | deriv |
| 31 Jan 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 99,518 | 0.00 USD | deriv |
| 31 Jan 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 173,467 | 0.00 USD | deriv |
| 18 Sept 2024 | SALE | Atea Pharmaceuticals, Inc. | 22,187 | 4.03 USD | |
| 17 Sept 2024 | SALE | Atea Pharmaceuticals, Inc. | 33,941 | 4.05 USD | |
| 19 Sept 2024 | SALE | Atea Pharmaceuticals, Inc. | 1,841 | 4.00 USD | |
| 05 Jun 2024 | SALE | Atea Pharmaceuticals, Inc. | 1,006 | 4.00 USD | |
| 31 Jan 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 173,467 | — | |
| 01 Feb 2024 | SALE | Atea Pharmaceuticals, Inc. | 56,910 | 3.85 USD | |
| 31 Jan 2024 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 448,000 | 0.00 USD | deriv |
| 31 Jan 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 173,467 | 0.00 USD | deriv |
| 01 Mar 2023 | OTHER | ABG Acquisition Corp. I | 32,500 | 0.00 USD | deriv |
| 31 Jan 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 728,600 | 0.00 USD | deriv |
| 31 Jan 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 520,400 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 378,033 | 0.00 USD | deriv |
| 28 Jun 2021 | GRANT_AWARD | Kezar Life Sciences, Inc. | 26,000 | 0.00 USD | deriv |